Adrenal Cortical Nodular Hyperplasia


Continuing Education Activity

A number of heterogeneous disorders can result in adrenal cortical nodular hyperplasia. Cortical hyperplasia is a benign enlargement of the gland. Normal adrenal gland size differs between two sides. They are characterized by signs and symptoms of Cushing syndrome due to increased cortisol secretion. This activity highlights the diagnosis and treatment of this condition by an interprofessional team.

Objectives:

  • Identify the etiology of nodular adrenal cortical hyperplasia medical conditions and emergencies.
  • Outline the appropriate evaluation of nodular adrenal cortical hyperplasia.
  • Review the management options available for nodular adrenal cortical hyperplasia.
  • Describe interprofessional team strategies for improving care coordination and communication to enhance outcomes for patients with adrenal cortical nodular hyperplasia.

Introduction

The adrenal glands are retroperitoneal structures, bilaterally located superior to the kidneys. They are highly vascularized organs. Adrenal glands have a couple of anatomically and physiologically separated segments, including cortex and medulla. The former one has three distinguished layers; glomerulosa, fasciculata, and reticularis, responsible for secreting aldosterone, cortisol, and androgens, respectively. They consequently regulate homeostasis. The second segment, medulla, mainly secretes epinephrine and norepinephrine, which are hormones essential during stress episodes.[1] Cortical hyperplasia is a benign enlargement of the gland. Normal adrenal gland size differs between two sides. The maximal normal width in the right and left adrenal glands are 0.61 and 0.79 cm, respectively.[1]

Etiology

A variety of etiologies for adrenal cortical hyperplasia has been described including ACTH-dependent and ACTH-independent causes, and also congenital adrenal hyperplasia. Moreover, a wide range of disorders may masquerade the signs and symptoms of adrenal cortical hyperplasia.

Cushing syndrome: Most commonly caused by abnormal corticosteroid intake. If an obvious history of glucocorticoid administration along with a variety of symptoms including visceral obesity, buffalo hump, moon face appearance, generalized abdominal and limb striae, and decreased bone mineral density exists, obtaining extra diagnostic tests would be unnecessary.[2] 

 Cushing disease, or hypophysial corticotropin producing adenoma, accounts for the vast majority of Cushing syndrome causalities. Although the discrete threshold of pituitary adenoma has not been identified yet, tumor size of equal or greater than 6 millimeters is highly indicative of Cushing disease as the cause of Cushing syndrome.[3] 

Ectopic ACTH, mostly due to paraneoplastic causalities, accounts for the second-most common cause of ACTH-dependent cortical hyperplasia. The three most common types include lung, bronchial carcinoid tumor, and small cell lung cancer.[2][4]

 ACTH-independent hypercortisolism or adrenal originated Cushing syndrome might occur due to a couple of causalities, including primary pigmented nodular adrenal disease (PPNAD) or ACTH-independent macronodular adrenal hyperplasia (AIMAH).[5] The former one is a benign situation and is categorized into those with or without association with the Carney complex. The latter one presents in the late 40s, mostly in male patients, and is characterized by extremely heavier adrenal glands, (almost 20 to 25 times).[5][6]

Epidemiology

Macronodular Adrenal Hyperplasia (MAH) is a very rare disorder and occurs in less than 1% of patients with endogenous Cushing syndrome. The prevalence of endogenous Cushing syndrome is approximately 1 in 26,000 people. MAH most commonly affects people in their 40s to 50s with no known sex predilection.[7] Patients with PPNAD present before age 30 years and in half of the cases before 15 years old.[8][9] Patients' sex and puberty state change the development of Cushing syndrome in PPNAD: after adolescence, PPNAD affects females more than males; by the age of 40, more than 70% of females with PRKAR1A mutation develop PPNAD, compared with 45% of males.[10]

Pathophysiology

Background pathophysiology mechanism of macronodular adrenal hyperplasia, which is generally described as the state of elevated level of cortisol, along with the decreased level of plasma adrenocorticotrophin (ACTH) has been implicated with several possible mechanisms including:

  1. Extraordinary increased expression of aberrant G-protein-coupled receptors which are located through the membranes of specific cells that are capable of producing estrogen via specific corresponding ligands.[11][12] 
  2. The indirect function of the abnormally enlarged adrenal tissue via the paracrine effect.[13] 
  3. Specific mutations with a couple of variable types, including germline and somatic ones that are evident in approximately 50% of those affected with bilateral macronodular adrenal hyperplasia (BMAH).[14]

Histopathology

In most of the cases, nodular cortical hyperplasia is ACTH-independent. The glands are massively enlarged, mimicking a neoplasm. The cortical nodules in the late-stage sometimes show a transformation from diffuse hyperplasia; these nodules are yellow and vary in size from 0.2 to over 4.0 cm. The nodules compose of fasciculata-type clear cells, reticularis-type cells, or a mixture of both cell types. Distinct nodules with zona glomerulosa hyperplasia and intervening cortical atrophy are observed in children with McCune-Albright syndrome.[15][16]

In PPNAD (sometimes referred to as “micronodular adrenal disease”), the glands are usually of normal size, although they can be small or slightly enlarged. Multiple pigmented cortical nodules are present with commonly seen intervening atrophic cortex.[17][18] The nodules may abut the corticomedullary junction, extend beyond the periadrenal fat, or involve cortical full thickness. Pigmentation is due to intracytoplasmic lipofuscin. The nodules compose of uniform eosinophilic cells with some balloon cells similar to the normal zona reticularis. The cells are strongly positive for synaptophysin but negative for chromogranin.[19] Occasional additional pathologic findings include microscopic foci of necrosis, mitotic figures, and a trabecular pattern of growth.[20]

History and Physical

A comprehensive organ-system and generalized physical examination, considering visceral or central obesity, increased blood pressure, purple skin striae, non-generalized muscle atrophy, and skin discoloration, should be undertaken to evaluate adrenal cortical hyperplasia. Every sign and symptom of elevated level of plasma and urinary cortisol, including significant weight gain, abnormal menstruation cycles, hirsutism, should be considered. 

Several other evidence of the indirect effect of hypercortisolisms including diminished bone mineral density, accumulated fat depositions in specific areas, like the posterior aspect of the neck and proximal to the clavicle, and fertility disturbances should raise suspicion for the adrenal cortical hyperplasia. In the presence of the mentioned signs and symptoms accompanied with a positive history of exogenous corticosteroid administration, there is a lack of demand for further diagnostic investigations. On the other hand, a variety of imaging and laboratory examinations, including brain MRI, chest and abdominal pelvic CT scan should be obtained to clarify the possible underlying cause of Cushing disease.[2]

Evaluation

Few patients affected with adrenal cortical hyperplasia might present with clinical and laboratory evidence of an increased level of aldosterone, including elevated blood pressure, decreased level of potassium, and disturbed arterial blood gas demonstrating metabolic alkalosis.[21] The elevated level of cortisol is well documented utilizing several specific laboratory examinations, including the measurement of unbounded cortisol in 24-hour collected urine, evaluating the effect of low dose dexamethasone suppression test, and the assessment of nocturnal salivary cortisol.[22] When the impression is Cushing syndrome (CS) with the laboratory evidence of an increased level of cortisol has been established, the exclusion of exogenous hypercortisolism should be prioritized.[23] Following exclusion of exogenous hypercortisolism, the stepwise diagnosis approach demands differentiation of a couple of major causalities; those which are dependent on ACTH secretion and those which are not dependant on ACTH secretion. To categorize the mentioned groups, plasma ACTH levels should be evaluated. Afterward, in case of any uncertainty in diagnosis, corticotropin-releasing hormone (CRH) assessment is recommended.[24] 

Further confirmatory tests, including serum aldosterone, and metanephrines, are highly recommended for those who are undiagnosed despite previously mentioned studies. In the majority of patients affected with Cushing syndrome, including pituitary adenoma, and ACTH hypersecretion due to ectopic causalities, the hypercortisolism is dependent on ACTH hypersecretion.[25] From the very early steps of evaluation, obtaining brain MRI and abdominal CT scan is recommended for ACTH-dependent and ACTH-independent, respectively.[26] To obtain the diagnosis, the patient’s age has a significant impact. Congenital adrenal hyperplasia, mostly diagnosed during childhood, is among ACTH-dependent types of Adrenal Hyperplasia. A variety of enzymatic defects are responsible; however, the most common defect responsible for CAH is the 21-hydroxylase deficiency. Therefore, screen testing for serum concentrations of 17-hydroxyprogesterone is among the screening tests that are routinely performed in the United States.[27][28]

Treatment / Management

Cushing disease, or hypophysial corticotropin producing adenoma, accounts for the vast majority of Cushing syndrome causalities. Although the discrete threshold of pituitary adenoma has not been identified yet, tumor size of equal or greater than 6 millimeters is highly indicative of Cushing disease as the causality of Cushing syndrome.[3] 

The treatment plan for pituitary adenomas mostly consists of transsphenoidal surgery by utilizing a microsurgical approach, which might cause up to 90%, and less than 70% absolute resolution in micro and macroadenomas, respectively.[29][30] The less common surgical approach in the treatment of Cushing's disease is utilizing endoscopic tumor resection, which has greatly improved the outcomes recently.[31]

Ectopic ACTH, mostly due to paraneoplastic causalities, accounts for the second-most common cause of ACTH-dependent cortical hyperplasia. The three most common types of the mentioned etiology of Cushing syndrome includes lung, bronchial carcinoid tumor, and small cell lung cancer.[2][4]

The treatment plan for ectopic ACTH depends on the functional status of the patient. In those affected with clinically symptomatic Cushing syndrome and acceptable functional status, surgical resection of the inciting tumor is highly recommended while medical treatment in those with poor functional status is preferred. Moreover, medical treatment might be prioritized in demanding emergent control of the elevated level of cortisol, and unknown primary tumor. On the other hand, the treatment plan for those with intractable hypercortisolism and inoperable Cushing syndrome due to ectopic ACTH hypersecretion, bilateral surgical resection of the adrenal glands, and long term hormone replacement is preferred.[32]

 ACTH-independent hypercortisolism or adrenal originated Cushing syndrome might occur due to a couple of causalities, including primary pigmented nodular adrenal disease (PPNAD) or ACTH-independent macronodular adrenal hyperplasia (AIMAH).[5] The former one is a benign situation and is categorized into those with or without association with the Carney complex. The treatment plan for both conditions with curative purpose is bilateral surgical resection of adrenal glands.[5][33] The latter one presents in the late 40s, mostly in male patients, and is characterized by extremely, almost 20 to 25 times, heavier adrenal glands. The treatment plan is similar to the former one, which consists of bilateral surgical removal of adrenal glands and lifelong glucocorticoid replacement.[5][6]

Differential Diagnosis

  • Adrenal cortical adenoma is usually unilateral and solitary, although bilateral adenomas have also been reported. They are often unencapsulated. The cut surface is yellow with brown foci.[34]
  • Pheochromocytoma is a rare, second most common tumor identified in adrenalectomy specimens and 7% of primary adrenal tumors.[35] The classic triad symptoms of episodic headaches, sweating, and tachycardia is seen in about 30% of the cases.[36] Histologic presentation overlaps with normal adrenal medulla.
  • Adrenocortical carcinoma is a rare very aggressive tumor with an estimated prevalence of between 0.5 and 12 per million.[37] The architecture is less ordered than in adenomas. Necrosis, increased mitosis, local invasion, and distant metastasis are common.
  • The other differentials include congenital adrenal hyperplasia, metastases, lymphoma, myelolipoma, amyloidosis, and infections involving adrenals such as tuberculosis, histoplasmosis, and blastomycosis.

Treatment Planning

Those patients with unilateral adrenal hyperplasia who meet the following criteria should be scheduled for surgical resection: (1) Suspicious malignancy regarding imaging criteria, (2) Those with greater than 4 to 6 cm size, and (3) Clinical evidence of functional adrenal mass, including every manifestation attributed to cortisol, aldosterone, or catecholamines hypersecretion.[38][39][40][41] Although there is a debate in discrete defining hypercortisolism due to cortisol hypersecretion, to cover the optimal management of those patients with mild hypercortisolism, there is a consensus in utilizing dexamethasone suppression test to identify those demanding intervention.

 In bilateral symmetrical hyperplasia along with an elevated level of urinary cortisol of greater than 3 to 4 times above normal, bilateral adrenalectomy might be recommended.[42] Furthermore, those with lower than three times elevation in urinary cortisol, and bilateral macronodular adrenal hyperplasia may experience relatively complete remission, but a significant 23% rate of recurrence is threatening.[43][44] Planning to resect only one of the adrenal glands remains controversial; some recommend removal of the larger gland or the one with higher radioactive agents uptake, while others recommend making decisions based on more invasive assessments, including the results of adrenal venous sampling. Careful follow up to exclude the post-procedural adrenal insufficiency is crucial as it might happen in up to 40%.[45]

Those patients affected with bilateral adrenal cortical hyperplasia due to hyperadrenalism might be considered for non-surgical treatment with mineralocorticoids antagonists, however, if the causality of adrenal cortical hyperplasia is supposed to be outstanding hypercortisolism, surgical management with bilateral surgical removal of adrenal glands and lifelong substitution of both glucocorticoid and mineralocorticoid should be considered.[46] 

Prognosis

Predicting the prognosis of the standard surgical approach of the adrenal cortical hyperplasia depends on a variety of factors. However, medical responsiveness to specific potassium-sparing diuretics, like spironolactone might be a reliable one and suggestive of good prognosis. On the contrary, chronic elevation of blood pressure, along with multiple organ failure, predicts a poor prognosis. Multiple organ failure, by definition, attributes to evidence of end-organ damage in at least a couple of vital organs.[47]

The overall survival of Cushing syndrome of all causes has significantly changed over the last 70 years from slightly more than 4.5 years in the early 1950s. Vascular compromise in the cardiac and nervous system, along with infectious related morbidities, were all found to be strong negative predictors on general outcomes and escalate the standard mortality ratio.[22]

Complications

Traditional surgical treatment of adrenal cortical hyperplasia harbors several complications, with the most common one being any type of bleeding, occurring during or after the surgical process in more than one out of five patients. Moreover, a couple of more surgery-related complications are incisional hernia and wound complications. Most predictable medical complication related to surgical adrenalectomy includes the metabolic effect of systemic elimination of cortisol. Among laparoscopic-related complications, infectious and thromboembolic morbidities are more common in devastating events.[48] In other words, surgical complications associated with adrenalectomy can be categorized based on the affected organ systems to include renal, cardiac, and pulmonary complications.[49]

Deterrence and Patient Education

Adrenal cortical hyperplasia is among the differential diagnosis of the adrenal incidentaloma. Following the exclusion of the exogenous corticosteroid intake, the stepwise laboratory and imaging investigations are highly recommended. Nodular adrenal cortical hyperplasia occurs in a couple of subtypes, including primary pigmented nodular adrenal disease (PPNAD) or ACTH-independent macronodular adrenal hyperplasia (AIMAH), which are both common in terms of a low level of ACTH, and elevated level of cortisol. Abdominal imaging, including CTscan and MRI, might elucidate characteristic findings relevant to the diagnosis. Definite curative treatment could be assumed via bilateral surgical resection of both glands and lifelong hormone replacement. 

Enhancing Healthcare Team Outcomes

The precise diagnosis of adrenal cortical nodular hyperplasia might be obtained through laboratory and imaging tests requested by endocrinologists. After exclusion of the differential diagnoses, the patient might need to be referred to general and/or laparoscopic surgeons to schedule the appropriate operation. As ablative procedure imposes the lifelong demand for glucocorticoid and mineralocorticoid replacement, the patient should be followed up by an interprofessional team, including surgeons and endocrinologists. During surgery, the anesthesiologist should be prepared for the most lethal and possible complications. Regarding the postoperative complications, the registered nurse is supposed to frequently check the vital signs to preclude the possible devastating and irreversible consequences of bleeding and thromboembolic events. In suspicious occasions of bleeding and thromboembolic events, timely management with fluid replacement and emergent anticoagulant initiation respectively, is preferred. The pathologist should precisely examine the specimen to confirm the diagnosis and exclude other possible differential diagnoses.


Article Details

Article Author

Saran Lotfollahzadeh

Article Editor:

Mehran Taherian

Updated:

6/2/2021 9:55:57 AM

References

[1]

Vincent JM,Morrison ID,Armstrong P,Reznek RH, The size of normal adrenal glands on computed tomography. Clinical radiology. 1994 Jul     [PubMed PMID: 8088036]

[2]

Lila AR,Sarathi V,Jagtap VS,Bandgar T,Menon P,Shah NS, Cushing's syndrome: Stepwise approach to diagnosis. Indian journal of endocrinology and metabolism. 2011 Oct     [PubMed PMID: 22145134]

[3]

Ejaz S,Vassilopoulou-Sellin R,Busaidy NL,Hu MI,Waguespack SG,Jimenez C,Ying AK,Cabanillas M,Abbara M,Habra MA, Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer. 2011 Oct 1     [PubMed PMID: 21412758]

[4]

Chaudhary V,Bano S, Imaging of the pituitary: Recent advances. Indian journal of endocrinology and metabolism. 2011 Sep     [PubMed PMID: 22029027]

[5]

Manipadam MT,Abraham R,Sen S,Simon A, Primary pigmented nodular adrenocortical disease. Journal of Indian Association of Pediatric Surgeons. 2011 Oct     [PubMed PMID: 22121318]

[6]

New MI,Wilson RC, Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proceedings of the National Academy of Sciences of the United States of America. 1999 Oct 26     [PubMed PMID: 10536001]

[7]

De Venanzi A,Alencar GA,Bourdeau I,Fragoso MC,Lacroix A, Primary bilateral macronodular adrenal hyperplasia. Current opinion in endocrinology, diabetes, and obesity. 2014 Jun     [PubMed PMID: 24739311]

[8]

Young WF Jr,Carney JA,Musa BU,Wulffraat NM,Lens JW,Drexhage HA, Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. The New England journal of medicine. 1989 Dec 14     [PubMed PMID: 2586567]

[9]

Zhou J,Zhang M,Bai X,Cui S,Pang C,Lu L,Pang H,Guo X,Wang Y,Xing B, Demographic Characteristics, Etiology, and Comorbidities of Patients with Cushing's Syndrome: A 10-Year Retrospective Study at a Large General Hospital in China. International journal of endocrinology. 2019     [PubMed PMID: 30915114]

[10]

Bertherat J,Horvath A,Groussin L,Grabar S,Boikos S,Cazabat L,Libe R,René-Corail F,Stergiopoulos S,Bourdeau I,Bei T,Clauser E,Calender A,Kirschner LS,Bertagna X,Carney JA,Stratakis CA, Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. The Journal of clinical endocrinology and metabolism. 2009 Jun     [PubMed PMID: 19293268]

[11]

Bourdeau I,D'Amour P,Hamet P,Boutin JM,Lacroix A, Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. The Journal of clinical endocrinology and metabolism. 2001 Nov     [PubMed PMID: 11701732]

[12]

Vassiliadi DA,Ntali G,Stratigou T,Adali M,Tsagarakis S, Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas. Endocrine. 2011 Dec     [PubMed PMID: 21598069]

[13]

Louiset E,Duparc C,Young J,Renouf S,Tetsi Nomigni M,Boutelet I,Libé R,Bram Z,Groussin L,Caron P,Tabarin A,Grunenberger F,Christin-Maitre S,Bertagna X,Kuhn JM,Anouar Y,Bertherat J,Lefebvre H, Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. The New England journal of medicine. 2013 Nov 28     [PubMed PMID: 24283225]

[14]

Assié G,Libé R,Espiard S,Rizk-Rabin M,Guimier A,Luscap W,Barreau O,Lefèvre L,Sibony M,Guignat L,Rodriguez S,Perlemoine K,René-Corail F,Letourneur F,Trabulsi B,Poussier A,Chabbert-Buffet N,Borson-Chazot F,Groussin L,Bertagna X,Stratakis CA,Ragazzon B,Bertherat J, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. The New England journal of medicine. 2013 Nov 28     [PubMed PMID: 24283224]

[15]

Carney JA,Young WF,Stratakis CA, Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome. The American journal of surgical pathology. 2011 Sep     [PubMed PMID: 21836496]

[16]

[Results of ACTH, vasopressin and insulin tolerance tests in obese subjects]., Eisner M,Derech K,Gołebiowska I,Krzyzanowska-Swiniarska B,, Annales Academiae Medicae Stetinensis, 1978     [PubMed PMID: 8008746]

[17]

[Behavior of acid beta-glycerophosphate phosphatases, acid para-nito- phenol phosphate phosphatases, beta-galactosidase and N-acetyl-beta-D-glucosaminidase in supernatant of amniotic fluid in the latent phase of the 1st stage of labor in groups of 30--40 and 41--42 week gestational age]., Sałyk A,, Annales Academiae Medicae Stetinensis, 1978     [PubMed PMID: 4085982]

[18]

Susceptibility to rhinovirus infection in chronic bronchitis., Monto AS,Bryan ER,, The American review of respiratory disease, 1978 Dec     [PubMed PMID: 6329005]

[19]

Phosphatidate phosphohydrolase activity in porcine pulmonary surfactant., Delahunty TJ,Spitzer HL,Jimenez JM,Johnston JM,, The American review of respiratory disease, 1979 Jan     [PubMed PMID: 1542635]

[20]

Regulation of airway smooth muscle tone in sleeping dogs., Sullivan CE,Zamel N,Kozar LF,Murphy E,Phillipson EA,, The American review of respiratory disease, 1979 Jan     [PubMed PMID: 2679153]

[21]

Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients., Brunner HR,Gavras H,Waeber B,Kershaw GR,Turini GA,Vukovich RA,McKinstry DN,Gavras I,, Annals of internal medicine, 1979 Jan     [PubMed PMID: 22499224]

[22]

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study., Kannel WB,Castelli WP,Gordon T,, Annals of internal medicine, 1979 Jan     [PubMed PMID: 18334580]

[23]

Recent developments in chemotherapy of narcotic addiction. Part VII. Evaluation of treatment effectiveness: defensive research--the Treatment Outcome Prospective Study (TOPS)., Ginzburg HM,, Annals of the New York Academy of Sciences, 1978     [PubMed PMID: 25639322]

[24]

Recent developments in chemotherapy of narcotic addiction. Part VII. Evaluation of present treatment modalities: research with DARP admissions, 1969-1973., Sells SB,Demaree RG,Simpson DD,Joe GW,, Annals of the New York Academy of Sciences, 1978     [PubMed PMID: 11932295]

[25]

Opiate receptors: some anatomical and physiological aspects., Kuhar MJ,, Annals of the New York Academy of Sciences, 1978     [PubMed PMID: 28639924]

[26]

Endorphins: physiology and clinical implications., Goldstein A,, Annals of the New York Academy of Sciences, 1978     [PubMed PMID: 25372578]

[27]

Pretracheal cervical granular cell myoblastoma., Polack EP,, Annals of plastic surgery, 1979 Jan     [PubMed PMID: 20823466]

[28]

Immunoassayable gastric inhibitory polypeptide: investigations into its role in carbohydrate metabolism., Morgan LM,, Annals of clinical biochemistry, 1979 Jan     [PubMed PMID: 16950973]

[29]

Efficacy of sodium diethyldithiocarbamate (dithiocarb) in acute nickel carbonyl poisoning., Sunderman FW,, Annals of clinical and laboratory science, 1979 Jan-Feb     [PubMed PMID: 18413427]

[30]

Hammer GD,Tyrrell JB,Lamborn KR,Applebury CB,Hannegan ET,Bell S,Rahl R,Lu A,Wilson CB, Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. The Journal of clinical endocrinology and metabolism. 2004 Dec     [PubMed PMID: 15579802]

[31]

Starke RM,Reames DL,Chen CJ,Laws ER,Jane JA Jr, Endoscopic transsphenoidal surgery for cushing disease: techniques, outcomes, and predictors of remission. Neurosurgery. 2013 Feb     [PubMed PMID: 23149974]

[32]

Wannachalee T,Turcu AF,Auchus RJ, Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome. Clinical endocrinology. 2018 Nov     [PubMed PMID: 30019523]

[33]

Effect of 9-(2-hydroxyethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits., Kaufman HE,Varnell ED,Centifanto YM,Rheinstrom SD,, Antimicrobial agents and chemotherapy, 1978 Dec     [PubMed PMID: 10966714]

[34]

McNicol AM, Lesions of the adrenal cortex. Archives of pathology & laboratory medicine. 2008 Aug     [PubMed PMID: 18684025]

[35]

Kulis T,Knezevic N,Pekez M,Kastelan D,Grkovic M,Kastelan Z, Laparoscopic adrenalectomy: lessons learned from 306 cases. Journal of laparoendoscopic & advanced surgical techniques. Part A. 2012 Jan-Feb     [PubMed PMID: 22166088]

[36]

Baguet JP,Hammer L,Mazzuco TL,Chabre O,Mallion JM,Sturm N,Chaffanjon P, Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. European journal of endocrinology. 2004 May     [PubMed PMID: 15132724]

[37]

Kinetic alpha-deuterium isotope effects for enzymatic and nonenzymatic hydrolysis of nicotinamide-beta-riboside., Ferraz JP,Bull HG,Cordes EH,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 12614096]

[38]

Effects of cyclic adenosine 3': 5'-monophosphate on phosphoprotein kinase and phosphatase fractions prepared from rat liver nuclei., Dokas L,Rittschof D,Kleinsmith LJ,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 21471169]

[39]

Purification and properties of bovine myocardial phosphorylase phosphatase (protein phosphatase C)., Killilea SD,Aylward JH,Mellgren RL,Lee EY,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 17287480]

[40]

Mechanism of lactic acid oxidation catalyzed by lactate dehydrogenase from the tail muscle of Homarus americanus., Eichner RD,Kaplan NO,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 19022420]

[41]

Isolation of elastin from bovine auricular cartilage., Field JM,Rodger GW,Hunter JC,Serafini-Fracassini A,Spina M,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 14768652]

[42]

The binding of products, metal ion, and a substrate analog to rabbit liver fructose bisphosphatase., Benkovic PA,Frey WA,Benkovic SJ,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 25971648]

[43]

The regulation of liver phosphoprotein phosphatase by inorganic pyrophosphate and cobalt., Khandelwal RL,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 25727927]

[44]

Respective role of superoxide and hydroxyl radical in the activity of the reconstituted microsomal ethanol-oxidizing system., Ohnishi K,Lieber CS,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 23592061]

[45]

Origin of tryptophan in fructose 1,6-bisphosphatase purified from livers of fed rabbits., Pontremoli S,Melloni E,Salamino F,Michetti M,Botelho LH,El-Dorry HA,Chu DK,Isaacs CE,Horecker BL,, Archives of biochemistry and biophysics, 1978 Dec     [PubMed PMID: 26330465]

[47]

On betaH-Leu5-endorphin and schizophrenia., Lewis RV,Gerber LD,Stein S,Stephen RL,Grosser BI,Velick SF,Udenfriend S,, Archives of general psychiatry, 1979 Feb     [PubMed PMID: 8634926]

[48]

The effects of hypophysectomy on the uptake and distribution of 3H-dopamine in the mouse adrenal medulla: an autoradiographic study., Hirano T,Kobayashi S,, Archivum histologicum Japonicum = Nihon soshikigaku kiroku, 1978 Nov     [PubMed PMID: 16980207]

[49]

[Pancreatic lesion in newborn mice caused by Coxsackie B1 virus]., Fingerland A,Vonfracková A,Horacek J,, Arkhiv patologii, 1978     [PubMed PMID: 8063073]